Clinical trial NCT05036408: Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions
Official title: Cancer Pain Rehabilitation Program in Cancer Survivorship Feasibility Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Lead sponsor: City of Hope Medical Center
Sponsor class: OTHER
Collaborators: name: National Cancer Institute (NCI)
First posted: 2021-09-05
Enrollment: 16
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: This clinical trial studies the effect of an interdisciplinary program with strong patient involvement on managing long-term chronic pain for cancer survivors. The purpose of this study is to determine whether enrolling patients into an interdisciplinary program can improve mobility with physical and occupational therapy and participation in online group psychotherapy that teaches coping skills to enhance quality of life.

Detailed description: PRIMARY OBJECTIVE:

I. To test the feasibility of an interdisciplinary functional restoration program in cancer survivors with chronic pain and restoring physical function.

EXPLORATORY OBJECTIVE:

I. To explore the preliminary effect of functional restoration program (FRP) in restoring physical function and reducing pain which ultimately decreases opioid consumption.

OUTLINE:

Patients participate in the cancer pain rehabilitation program for 6 weeks, including educational sessions over 2 hours once weekly, group psychological interventions, group physical therapy, and 1:1 physical and occupational therapy treatment per the patient's treatment plan. Patients may also undergo osteopathic manual treatments per physical and occupational therapy assessments.

After completion of study intervention, patients are followed up at 3 months.

Eligibility criteria: Inclusion Criteria:

* This study will be conducted in those with history of cancer in remission or with stable disease living with chronic pain greater than 6 months in duration
* Cancer survivors or stable indolent cancer patients ages 18 or older living with chronic pain
* All subjects must have the ability to understand and the willingness to sign a written informed consent
* Patients are required to have access to a computer with a camera and a reliable internet connection. The education lectures and psychotherapy group components of the program are facilitated via online Health Insurance Portability and Accountability Act (HIPPA) compliant platform
* Eligible participants will be able to read and write and speak English and be motivated and able to commit to attending six consecutive weekly group and individual sessions

Exclusion Criteria:

* Patients who are less than the age of 18 or have active problems with addiction will be excluded:

  * Those identified with illicit substance abuse or addiction will be referred to an addiction specialist or medication assisted treatment program through our resource coordinator
  * "Active substance abuse" exclusion was defined using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) Criteria which is the gold standard for diagnosing substance use disorders is a cluster of cognitive, behavioral and physiological symptoms indicated that the individual continues using the substance despite significant substance related problems
  * The substances that were considered are listed below:

    * Alcohol
    * Cannabis
    * Hallucinogens
    * Inhalants
    * Opioids
    * Sedatives (hypnotics or anxiolytics)
    * Stimulants
  * Overall, the diagnosis was based on pathological patterns of behaviors related to the use of the substance. Criteria that fit with overall groupings include impaired control, social impairment, risky use, and pharmacological criteria
* Impaired control

  * The individual may express overall desire to cut down or regulate substance use and may report multiple unsuccessful efforts to decrease or discontinue use
  * The individual may spend a great deal of time obtaining the substance, using the substance, or recovering from its affects
  * The individual's daily activities revolve around the substance in some instances of more severe substance use disorder
  * Craving is manifested by intense desire or urge for the drug that may occur at any time
* Social impairment

  * Recurrent substance use may result in failure to fulfill major role obligations at work, school, or home
  * The individual may continue substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance
  * Important social, occupational, or recreational activities may be given up or reduced because of substance use
  * The individual may withdraw from family activities and hobbies in order to use the substance
* Risky use

  * Recurrent use in situations in which it is physically hazardous
  * The individual may continue substance use despite knowledge of having persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance
* Pharmacologic criteria

  * Tolerance is signaled by requiring a markedly increased dose of substance to achieve the desired effect or markedly reduced effect when the usual dose is consumed
  * Withdrawal is a syndrome that occurs when blood or tissue concentrations of a substance decline in an individual who had maintained a prolonged heavy use of the substance
  * After developing withdrawal symptoms, the individual is likely to consume the substance to relieve the symptoms

    * Symptoms of tolerance or withdrawal occurring during appropriate medication treatment with prescribed medications are specifically not counted. However, prescription medications can be used inappropriately based on criteria above and substance use disorder can be correctly diagnosed when there are other symptoms of compulsive and drug seeking behavior
* Substance use disorders occur in a broad range of severity from mild to severe with severity based on number of symptom criteria endorsed.

  * Mild

    * Presence of 2-3 symptoms
  * Moderate

    * Presence of 4-5 symptoms
  * Severe

    * Presence of 6-7 symptoms
* For our research purposes, our exclusion criteria included any individual who met criteria for mild, moderate, and severe substance use disorder
* Those with severe cognitive or psychiatric impairments that preclude participation in group sessions will be excluded
* Patients should not have any uncontrolled illness of any kind including ongoing or active infection
* Subjects, who are not be able to comply with the safety monitoring requirements of the study. Those who miss more than half the sessions will be considered to not have completed the program

Primary outcomes:
measure: Feasibility of Functional Restoration Program
timeFrame: 24 months from the intervention date
Secondary outcomes:
Other outcomes:
measure: Preliminary effect of the Functional Restoration Program in reducing pain (NSR)
timeFrame: Pre-intervention , End of intervention (6 weeks), 3 months post-intervention
measure: Preliminary effect of the Functional Restoration Program in reducing pain (PSEQ)
timeFrame: Pre-intervention, End of intervention (6 weeks), 3 months post-intervention
measure: Preliminary effect of the Functional Restoration Program to restore physical function (ADL)
timeFrame: Pre-intervention, End of intervention (6 weeks), 3 months post-intervention
measure: Preliminary effect of the Functional Restoration Program to restore physical function (OARS)
timeFrame: Pre-intervention, End of intervention (6weeks), 3 months post-intervention
measure: Preliminary effect of the Functional Restoration Program to restore physical function (6MWT)
timeFrame: Pre-intervention, End of intervention (6 weeks), 3 months post-intervention
measure: Preliminary effect of the Functional Restoration Program to restore physical function (10mWT)
timeFrame: Pre-intervention, End of intervention (6 weeks), 3 months post-intervention
Locations:
city: Duarte
country: United States
facility: City of Hope Medical Center
state: California
Study officials:
affiliation: City of Hope Medical Center
name: Heather N Bitar
role: PRINCIPAL_INVESTIGATOR
References: